Matsuda Masaru
Related Filers (2)
Other (2)
144
Tuesday, 11/21/2023
Filing for proposed sale of securities under Rule 144
144
Wednesday, 5/31/2023
Filing for proposed sale of securities under Rule 144
Ownership (17)
4
Thursday, 2/15/2024
Arcutis Biotherapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 1/17/2024
Arcutis Biotherapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 11/21/2023
Arcutis Biotherapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 6/2/2023
Arcutis Biotherapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 3/6/2023
Arcutis Biotherapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 11/22/2022
Arcutis Biotherapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 6/2/2022
Arcutis Biotherapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 3/7/2022
Arcutis Biotherapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 1/5/2022
Arcutis Biotherapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Wednesday, 1/5/2022
Arcutis Biotherapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 9/7/2021
HALOZYME THERAPEUTICS, INC.: Statement of changes in beneficial ownership of securities
4
Wednesday, 2/17/2021
HALOZYME THERAPEUTICS, INC.: Statement of changes in beneficial ownership of securities
4
Friday, 2/12/2021
HALOZYME THERAPEUTICS, INC.: Statement of changes in beneficial ownership of securities
4
Friday, 9/4/2020
HALOZYME THERAPEUTICS, INC.: Statement of changes in beneficial ownership of securities
4
Thursday, 2/13/2020
HALOZYME THERAPEUTICS, INC.: Statement of changes in beneficial ownership of securities
4
Wednesday, 2/12/2020
HALOZYME THERAPEUTICS, INC.: Statement of changes in beneficial ownership of securities
3
Monday, 1/6/2020
HALOZYME THERAPEUTICS, INC.: Initial statement of beneficial ownership of securities